Austar Lifesciences Limited (HKG:6118)
Hong Kong · Delayed Price · Currency is HKD 0.9200
+0.0200 (2.22%)
Jan 21, 2026, 4:08 PM HKT
Austar Lifesciences Market Cap
Austar Lifesciences has a market cap or net worth of 461.32 million as of January 21, 2026. Its market cap has increased by 52.54% in one year.
Market Cap
461.32M
Enterprise Value
672.27M
Revenue
1.60B
Ranking
n/a
PE Ratio
11.96
Stock Price
0.92
Market Cap Chart
Since November 7, 2014, Austar Lifesciences's market cap has decreased from 1.79B to 461.32M, a decrease of -74.16%. That is a compound annual growth rate of -11.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 461.32M | 3.45% |
| Dec 31, 2025 | 445.95M | 52.63% |
| Dec 31, 2024 | 292.17M | -63.46% |
| Dec 29, 2023 | 799.63M | -22.77% |
| Dec 30, 2022 | 1.04B | -86.60% |
| Dec 31, 2021 | 7.73B | 147.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |